A total of @ BC patients ( @-@ years , pN@ ) were entered into a randomized phase III trial comparing @ E@C@ q@w followed by @ docetaxel @ q@w ( n = @ ) with the current standard : @ F@E@C@ q@w ( n = @ ) or C@M@F@ d@ , @ q@w ( n = @ ) .